Recursion Pharmaceuticals

View All

Recent Pharma News
Recursion Pharmaceuticals nets USD 121M; Bayer’s MRI agent gets a nod

AI-powered drug-maker Recursion Pharmaceuticals secures USD 121 M to accelerate its clinical programs Recursion Pharmaceuticals, a next-gen biopharma company, has raised USD 121 Million in Series C financing. The Series C round was led by Baillie Gifford's flagship investment trust, Scottish Mortgage Investment...

Find More